Cintas DOWNGRADED to Mkt Perform and 4 Analyst-Downgraded Shares

July 17, 2012

Wall St. Watchdog reveals information about companies for which stock analysts downgraded the shares on July 17th.

Questar (NYSE:STR): Barclays downgraded its rating on this company from Overweight to Equal Weight.

Don’t Miss: Coca-Cola Earnings: Consecutive Profit Quarter Streak SUCCESS.

Weyerhaeuser (NYSE:WY): BMO Capital Markets downgraded its rating on this company from Market Perform to Underperform.

Human Genome (NASDAQ:HGSI): Summer Street Research downgraded its rating on this company from Buy to Neutral.

Cintas (NASDAQ:CTAS): Barrington Research downgraded its rating on this company from Outperform to Mkt Perform.

New Oriental Education & Technology (NYSE:EDU): Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target from $32 to $19.

Don’t Miss: Why Are Ford Sales SLUMPING?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com